You are here

Pharma CEOs

AngioDynamics CEO Clemmer is on the M&A trail

Mass Device

Fri, 07/13/18 - 11:07 pm

Sen. Wyden probes 'secret, sweetheart' deal between Pfizer, Trump

Fierce Pharma

Thu, 07/12/18 - 06:18 pm

Trump invites pharma heads to private dinner during London visit, a trip that’s inspiring tens of thousands to protest

Endpoints

Thu, 07/5/18 - 11:22 am

Sanofi’s Andre Turenne Is Slated to Become Voyager Therapeutics CEO

Xconomy

Wed, 07/4/18 - 10:12 am

Voyager Therapeutics

Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post

Xconomy

Mon, 07/2/18 - 10:23 pm

Deborah Dunsire

Sprout's old CEO is back, and she's got some new marketing ideas for female libido drug Addyi

Fierce Pharma

Tue, 06/12/18 - 10:37 pm

Sprout Pharmaceuticals

Cindy Whitehead

Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs

Endpoints

Tue, 06/12/18 - 10:31 pm

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Fierce Pharma

Mon, 06/11/18 - 05:17 pm

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Xconomy

Mon, 06/4/18 - 10:07 pm

Portola Pharmaceuticals

Takeda CEO Sees Path to Survival in Shire Megadeal

Bloomberg

Thu, 05/17/18 - 10:25 pm

Former Novartis CEO Explains Why His Company Paid Trump Lawyer Michael Cohen $1.2 Million

Forbes

Wed, 05/16/18 - 11:04 am

Novartis CEO Vas Narasimhan faces a heap of burning questions — but so far offers no public answers

Endpoints

Tue, 05/15/18 - 09:11 pm

Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card

BioSpace

Sat, 05/12/18 - 11:38 am

Akari Therapeutics

David Horn Solomon

‘Not a good day for Novartis’: CEO tries to reassure employees amid fury over payments to Trump’s lawyer

Stat

Thu, 05/10/18 - 11:12 pm

Vasant Narasimham

Drugmaker Novartis plays down its deal with Trump’s lawyer, tying it to its former CEO

Marketwatch

Wed, 05/9/18 - 09:18 am

Vasant Narasimham

No need for a megadeal, Pfizer CEO says. We'll grow despite looming Lyrica generics

Fierce Pharma

Tue, 05/1/18 - 09:34 pm

Saunders: All options remain on the table for Allergan

Biopharma Dive

Mon, 04/30/18 - 07:35 pm

Biotech stars Schleifer and Yancopoulos share $52M in 2017 compensation, even though Regeneron’s share price swooned

Endpoints

Tue, 04/24/18 - 10:10 am

George Yancopoulos

Novartis CEO Vas Narasimhan is raising the bar on second-gen cancer drug studies

Endpoints

Sat, 04/21/18 - 12:44 pm

How big is too big for a CEO bonus target? Annoyed Shire investors have some ideas

Fierce Pharma

Wed, 04/18/18 - 07:20 pm

Flemming Ornskov

Pages